Nurix Therapeutics, Inc. Quarterly Accounts Payable, Current in USD from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Nurix Therapeutics, Inc. quarterly Accounts Payable, Current history and growth rate from Q4 2019 to Q3 2024.
  • Nurix Therapeutics, Inc. Accounts Payable, Current for the quarter ending August 31, 2024 was $3.92M, a 79.2% increase year-over-year.
Accounts Payable, Current, Quarterly (USD)
Accounts Payable, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $3.92M +$1.73M +79.2% Aug 31, 2024 10-Q 2024-10-11
Q2 2024 $2.81M -$1.71M -37.8% May 31, 2024 10-Q 2024-07-11
Q1 2024 $5.92M +$289K +5.13% Feb 29, 2024 10-Q 2024-04-10
Q4 2023 $6.4M +$1.34M +26.4% Nov 30, 2023 10-Q 2024-10-11
Q3 2023 $2.19M -$3.87M -63.9% Aug 31, 2023 10-Q 2023-10-12
Q2 2023 $4.53M -$1.62M -26.3% May 31, 2023 10-Q 2023-07-13
Q1 2023 $5.63M -$385K -6.4% Feb 28, 2023 10-Q 2023-04-13
Q4 2022 $5.06M -$1.59M -23.9% Nov 30, 2022 10-K 2024-02-15
Q3 2022 $6.05M +$2.19M +56.8% Aug 31, 2022 10-Q 2022-10-06
Q2 2022 $6.14M +$737K +13.6% May 31, 2022 10-Q 2022-07-07
Q1 2022 $6.01M +$1.63M +37.1% Feb 28, 2022 10-Q 2022-04-08
Q4 2021 $6.65M +$3.24M +94.9% Nov 30, 2021 10-K 2023-02-09
Q3 2021 $3.86M +$250K +6.92% Aug 31, 2021 10-Q 2021-10-14
Q2 2021 $5.41M May 31, 2021 10-Q 2021-07-13
Q1 2021 $4.39M Feb 28, 2021 10-Q 2021-04-13
Q4 2020 $3.41M +$1.81M +114% Nov 30, 2020 10-K 2022-01-28
Q3 2020 $3.61M Aug 31, 2020 10-Q 2020-10-14
Q4 2019 $1.6M Nov 30, 2019 10-K 2021-02-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.